On the mechanism of tumor cell entry of aloe-emodin, a natural compound endowed with anticancer activity

被引:2
作者
Pecere, Teresa [1 ]
Ponterio, Eleonora [1 ]
Di Iorio, Enzo [1 ]
Carli, Modesto [2 ]
Fassan, Matteo [4 ]
Santoro, Luisa [5 ]
Bissaro, Maicol [3 ]
Bernabe, Giulia [1 ]
Moro, Stefano [3 ]
Castagliuolo, Ignazio [1 ]
Palu, Giorgio [1 ]
机构
[1] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy
[2] Univ Padua, Dept Womens & Childrens Hlth, Hematol Oncol Div, Padua, Italy
[3] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Mol Modeling Sect MMS, Padua, Italy
[4] Univ Padua, Dept Med, Padua, Italy
[5] Azienda Osped Padova, Padua, Italy
关键词
aloe-emodin; anticancer activity; somatostatin receptor; SOMATOSTATIN RECEPTOR; EXPRESSION; PROLIFERATION; INHIBITION; CANCER;
D O I
10.1002/ijc.33686
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aloe-emodin (1,8-dihydroxy-3-[hydroxymethyl]-anthraquinone), AE, is one of the active constituents of a number of plant species used in traditional medicine. We have previously identified, for the first time, AE as a new antitumor agent and shown that its selective in vitro and in vivo killing of neuroblastoma cells was promoted by a cell-specific drug uptake process. However, the molecular mechanism underlying the cell entry of AE has remained elusive as yet. In this report, we show that AE enters tumor cells via two of the five somatostatin receptors: SSTR2 and SSTR5. This observation was suggested by gene silencing, receptor competition, imaging and molecular modeling experiments. Furthermore, SSTR2 was expressed in all surgical neuroblastoma specimens we analyzed by immunohistochemistry. The above findings have strong implications for the clinical adoption of this natural anthraquinone molecule as an antitumor agent.
引用
收藏
页码:1129 / 1136
页数:8
相关论文
共 25 条
[1]   Somatostatin receptor expression in hepatocellular carcinoma: prognostic and therapeutic considerations [J].
Abdel-Rahman, Omar ;
Lamarca, Angela ;
Valle, Juan W. ;
Hubner, Richard A. .
ENDOCRINE-RELATED CANCER, 2014, 21 (06) :R485-R493
[2]   Somatostatin receptor gene expression in neuroblastoma [J].
Albers, AR ;
O'Dorisio, MS ;
Balster, DA ;
Caprara, M ;
Gosh, P ;
Chen, F ;
Hoeger, C ;
Rivier, J ;
Wenger, GD ;
O'Dorisio, TM ;
Qualman, SJ .
REGULATORY PEPTIDES, 2000, 88 (1-3) :61-73
[3]   Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma [J].
Alexander, Natasha ;
Marrano, Paula ;
Thorner, Paul ;
Naranjo, Arlene ;
Van Ryn, Collin ;
Martinez, Daniel ;
Batra, Vandana ;
Zhang, Libo ;
Irwin, Meredith S. ;
Baruchel, Sylvain .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (03) :222-227
[4]   Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-η-dependent inhibition of extracellularly regulated kinase-1/2 [J].
Barbieri, Federica ;
Pattarozzi, Alessandra ;
Gatti, Monica ;
Porcile, Carola ;
Bajetto, Adriana ;
Ferrari, Angelo ;
Culler, Michael D. ;
Florio, Tullio .
ENDOCRINOLOGY, 2008, 149 (09) :4736-4746
[5]   Voltage-dependent modulation of single N-type Ca2+ channel kinetics by receptor agonists in IMR32 cells [J].
Carabelli, V ;
Lovallo, M ;
Magnelli, V ;
Zucker, H ;
Carbone, E .
BIOPHYSICAL JOURNAL, 1996, 70 (05) :2144-2154
[6]   Photodynamic Therapy Mediated by Aloe-Emodin Inhibited Angiogenesis and Cell Metastasis Through Activating MAPK Signaling Pathway on HUVECs [J].
Chen, Qing ;
Li, Kai-Ting ;
Tian, Si ;
Yu, Ting-He ;
Yu, Le-Hu ;
Lin, Hai-Dan ;
Bai, Ding-Qun .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17 :1-11
[7]   Characterization of an anthraquinone fluor from the bioluminescent, pelagic polychaete Tomopteris [J].
Francis, Warren R. ;
Powers, Meghan L. ;
Haddock, Steven H. D. .
LUMINESCENCE, 2014, 29 (08) :1135-1140
[8]   Differentiated Expression of Somatostatin Receptor Subtypes in Experimental Models and Clinical Neuroblastoma [J].
Georgantzi, Kleopatra ;
Tsolakis, Apostolos V. ;
Stridsberg, Mats ;
Jakobson, Ake ;
Christofferson, Rolf ;
Janson, Eva Tiensuu .
PEDIATRIC BLOOD & CANCER, 2011, 56 (04) :584-589
[9]   Anticancer Potential of Aloes: Antioxidant, Antiproliferative, and Immunostimulatory Attributes [J].
Harlev, Eli ;
Nevo, Eviatar ;
Lansky, Ephraim P. ;
Ofir, Rivka ;
Bishayee, Anupam .
PLANTA MEDICA, 2012, 78 (09) :843-852
[10]   Development and validation of a genetic algorithm for flexible docking [J].
Jones, G ;
Willett, P ;
Glen, RC ;
Leach, AR ;
Taylor, R .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (03) :727-748